VRCA · Verrica Pharmaceuticals Inc. · Executive Compensation
$4.80
+0.34 (+7.51%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$75.07M
Shares
17.18M
Volume · Sep 30
50.99K
Avg daily vol (3M)
62.01K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Christopher G. Hayes | Former Chief Legal Officer | $747,579 |
| Jayson Rieger | President and Chief Executive Officer | $741,403 |
| John J. Kirby | Interim Chief Financial Officer | $614,600 |
| John Kirby | Interim Chief Financial Officer | $614,600 |
| Gary Goldenberg | Former Chief Medical Officer | $363,127 |
| Noah Rosenberg | Chief Medical Officer | $347,588 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ted White | Former President and Chief Executive Officer | $2,594,832 |
| Joe Bonaccorso | Former Chief Commercial Officer | $1,279,038 |
| Jayson Rieger | President and Chief Executive Officer | $1,236,225 |
| Christopher G. Hayes | Chief Legal Officer | $1,028,062 |
| Gary Goldenberg | Former Chief Medical Officer | $973,317 |
| John J. Kirby | Interim Chief Financial Officer | $114,587 |
| John Kirby | Interim Chief Financial Officer | $114,587 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ted White | Former President and Chief Executive Officer | $3,504,647 |
| Christopher G. Hayes | Chief Legal Officer | $2,561,674 |
| Joe Bonaccorso | Former Chief Commercial Officer | $2,097,472 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,935,834 |
| Joe Bonaccorso | Chief Commercial Officer | $986,518 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joe Bonaccorso | Chief Commercial Officer | $1,224,333 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,706,704 |
| Gary Goldenberg | Chief Medical Officer | $1,514,036 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,441,189 |
| A. Brian Davis | Chief FinancialOfficer | $1,339,581 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lawrence Eichenfield | director | Appointed | 2026-06-09 |
| Paul B. Manning | director | Appointed | 2026-06-09 |
| Charles Frantzreb | director | Appointed | 2025-12-30 |
| Christopher G. Hayes | Chief Legal Officer, Chief Compliance Officer and Corporate Secretary | Resigned | 2025-04-25 |
| Gavin Corcoran | director | Appointed | 2025-04-02 |
| David Zawitz | Chief Operating Officer and Principal Operating Officer | Appointed | 2024-12-09 |
| John Kirby | interim Chief Financial Officer | Appointed | 2024-11-04 |
| Jayson Rieger | director | Appointed | 2024-11-04 |
| Jayson Rieger | President and Chief Executive Officer | Appointed | 2024-11-04 |
| John Kirby | Interim Chief Financial Officer | Appointed | 2024-11-04 |
| Jayson Rieger | Chief Executive Officer | Appointed | 2024-11-04 |
| John J. Kirby | Interim Chief Financial Officer | Appointed | 2024-11-04 |
| Dr. Jayson Rieger | member of the Board | Appointed | 2024-11-04 |
| Dr. Jayson Rieger | President, Chief Executive Officer, and as member of the Board | Appointed | 2024-11-04 |
| Ted White | member of the Company's Board of Directors | Resigned | 2024-11-04 |
| Ted White | President and Chief Executive Officer | Resigned | 2024-11-04 |
| Craig Ballaron | member of the Board of Directors | Resigned | 2024-10-08 |
| Terence Kohler | Chief Financial Officer | Resigned | 2024-09-27 |
| Joe Bonaccorso | Chief Commercial Officer | Resigned | 2024-08-27 |